Rockefeller Science Funding: The Long And Short of It

If you’ve got an idea for a research project that could save the world if only you could get a few million dollars of funding, don’t bother call. ing the Rockefeller Foundation. If they have an interest in such a grand-scale science effort, they’ll hand- pick the scientists they want to work on it. On the other hand, if you’re more modestly inclined investigator whose proposal requires less than $100,000, you might indeed do well to ring up the folks at Rockefeller, whi

Written byAnne Moffat
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

If you’ve got an idea for a research project that could save the world if only you could get a few million dollars of funding, don’t bother call. ing the Rockefeller Foundation. If they have an interest in such a grand-scale science effort, they’ll hand- pick the scientists they want to work on it. On the other hand, if you’re more modestly inclined investigator whose proposal requires less than $100,000, you might indeed do well to ring up the folks at Rockefeller, which takes two distinctly different approaches to doling out its riches— one for established investigators, the other for newcomers. Although it is best known for its multimillion-dollar support of basic and applied research—often carried out by already-eminent researchers—the 76-year-old foundation also distributes dozens of grants-in-aid each year to scientists who submit unsolicitied proposals requesting $100,000 or less. Approved on the signature of a program officer and the foundation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies